[Treatment of hypertension. 3. Antihypertensive agents affecting catecholamine metabolism].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000378:metabolism*; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use; D013564:Sympathetic Nervous System / Q000187:drug effects*
D000959:Antihypertensive Agents; D002395:Catecholamines; D006146:Guanidines; D008996:Monoamine Oxidase Inhibitors; D008750:Methyldopa
Die Behandlung des hohen Blutdrucks. 3. Antihypertensive Substanzen mit Einfluss auf den Katecholaminstoffwechsel.